SCHEMBL8201082

SCHEMBL8201082

Nc1scc(-c2cccs2)c1C(=O)O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.77
ALDH1A1 P00352 6/20 0.77
HPGD P15428 4/20 0.77
KDM4E B2RXH2 4/20 0.77
GAA P10253 2/20 0.77
TSHR P16473 1/20 0.77
HSD17B10 Q99714 1/20 0.77
KEAP1 Q14145 1/20 0.63
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
LMNA P02545 3/20 0.56
USP2 O75604 1/20 0.56
PRKCZ Q05513 1/20 0.44
TP53 P04637 3/20 0.42
POLB P06746 2/20 0.42
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
HIF1A Q16665 1/20 0.40
DAO P14920 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18177337 0.87 MAPT (1.00) MAPTALDH1A1HPGDKDM4EGAA
SCHEMBL5322468 0.81 MAPT (0.73) MAPTALDH1A1HPGDKDM4EGAA
SCHEMBL689546 0.78 ALDH1A1 (1.00) MAPTALDH1A1HPGDKDM4EGAA
SCHEMBL1799330 0.77 KMT2A (0.69) MAPTALDH1A1HPGDKDM4EGAA
SCHEMBL8196570 0.75 ALDH1A1 (0.62) MAPTALDH1A1HPGDKDM4EGAA
SCHEMBL8188234 0.75 KMT2A (0.65) MAPTALDH1A1HPGDKDM4EGAA
SCHEMBL27749754 0.73 HSD17B10 (0.63) MAPTALDH1A1HPGDKDM4EGAA
SCHEMBL13838083 0.72 PRKCZ (0.61) MAPTALDH1A1HPGDKDM4EGAA
SCHEMBL12465762 0.72 PRKCZ (0.47) MAPTALDH1A1HPGDKDM4EGAA
SCHEMBL28760465 0.72 ALDH1A1 (0.54) MAPTALDH1A1HPGDKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008063668-A1 HETEROBICYCLIC METALLOPROTEASE INHIBITORS ALANTOS PHARMACEUTICALS HOLDING, INC. (US) 2008-05-29 WO disclosed